Benefit of salvage total pharyngolaryngoesophagectomy for recurrent locally advanced head and neck cancer after radiotherapy

被引:9
|
作者
Liu, Jie [1 ]
Zhang, Ye [2 ]
Li, Zhengjiang [1 ]
Liu, Shaoyan [1 ]
Li, Huizheng [3 ]
Xu, Zhengang [1 ]
机构
[1] Chinese Acad Med Sci, Peking Union Med Coll, Dept Head & Neck Surg Oncol, Natl Canc Ctr,Canc Hosp, 17 Panjiayuan Nanli,Head & Neck Ward 1, Beijing 100021, Peoples R China
[2] Chinese Acad Med Sci, Peking Union Med Coll, Dept Radiat Oncol, Natl Canc Ctr,Canc Hosp, Beijing, Peoples R China
[3] Dalian Friendship Hosp, Dept Otorhinolaryngol, Dalian, Peoples R China
来源
RADIATION ONCOLOGY | 2017年 / 12卷
关键词
SQUAMOUS-CELL CARCINOMA; PROGNOSTIC-FACTORS; RANDOMIZED-TRIALS; LARYNGEAL-CANCER; SURGERY; THERAPY; FAILURE; CHEMORADIATION;
D O I
10.1186/s13014-017-0900-2
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: The treatment modalities for recurrent locally advanced head and neck cancer failure after radiotherapy are limited with poor prognosis. Salvage supra-radical operation seems to be an option. It has not been established which patients will benefit from salvage total pharyngolaryngoesophagectomy. Methods: We retrospectively reviewed 66 patients with previously irradiated recurrent T4 head and neck cancer who underwent salvage total pharyngolaryngoesophagectomy at our institution between January 2001 and June 2014. The clinical outcome and toxicities were analyzed. Results: Flap loss occurred in 2 patients, and the incidence of fistulas and anastomosis strictures was 15.6% (10/66) and 13.6% (9/66), respectively. The median survival time of the entire cohort was 12 months. The interval between radiation and salvage surgery, and microscopic carotid artery invasion were identified as independent prognostic factors for overall survival. The 3-year overall survival rates of patients with (n = 33) and without (n = 33) risk factors were 9.1% and 47.2%, respectively (p = 0.007). A time interval between radiation and salvage surgery <= 6 months and previous concurrent chemotherapy or targeted therapy were risk factors for severe post-operative complications. Conclusions: Salvage total pharyngolaryngoesophagectomy is beneficial to selected patients with recurrent locally advanced head and neck cancer after radiotherapy.
引用
收藏
页数:6
相关论文
共 50 条
  • [31] Salvage brachytherapy and a rectal spacer in locally recurrent prostate cancer after radiotherapy
    Crehange, G.
    Cormier, L.
    Bertaut, A.
    Peiffert, D.
    Bolla, M.
    Chapet, O.
    Rio, E.
    De Crevoisier, R.
    Martin, E.
    Cosset, J. M.
    RADIOTHERAPY AND ONCOLOGY, 2018, 127 : S851 - S852
  • [32] Salvage radiotherapy for palpable, locally recurrent prostate cancer after radical prostatectomy
    Macdonald, K
    Schild, SE
    Vora, SA
    Andrews, PE
    Ferrigni, RG
    Novicki, DE
    Swanson, SK
    Wong, WW
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2004, 58 (05): : 1530 - 1535
  • [33] Salvage brachytherapy for locally recurrent prostate cancer after external beam radiotherapy
    Yamada, Yasuhiro
    Okihara, Koji
    Iwata, Tsuyoshi
    Masui, Koji
    Kamoi, Kazumi
    Yamada, Kei
    Miki, Tsuneharu
    ASIAN JOURNAL OF ANDROLOGY, 2015, 17 (06) : 899 - 903
  • [34] Results of salvage neck dissection after chemoradiation in locally advanced head and neck squamous cell carcinoma
    L. López
    P. García-Cabo
    J. L. Llorente
    F. López
    J. P. Rodrigo
    European Archives of Oto-Rhino-Laryngology, 2024, 281 : 945 - 951
  • [35] Results of salvage neck dissection after chemoradiation in locally advanced head and neck squamous cell carcinoma
    Lopez, L.
    Garcia-Cabo, P.
    Llorente, J. L.
    Lopez, F.
    Rodrigo, J. P.
    EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY, 2024, 281 (02) : 945 - 951
  • [36] Nivolumab and ipilimumab in combination with radiotherapy in patients with locally advanced head and neck cancer
    Johnson, J. M.
    Bar Ad, V.
    Lorber, E.
    Luginbuhl, A.
    Curry, J. M.
    Cognetti, D.
    Keith, S.
    Axelrod, R.
    Zinner, R.
    Rodeck, U.
    Harshyne, L. A.
    Argiris, A.
    ANNALS OF ONCOLOGY, 2018, 29
  • [37] Is there any use in accelerated and hyperfractionated radiotherapy in locally advanced head and neck cancer?
    Monney, M
    Allal, A
    Guilleman, C
    Rosset, A
    Miralbell, R
    Kurtz, J
    Mirimanoff, RO
    EUROPEAN JOURNAL OF CANCER, 1997, 33 : 831 - 831
  • [38] Radiotherapy combined with cetuximab for locally advanced head and neck cancer: Results and toxicity
    Acevedo-Henao, C. M.
    Valette, G.
    Miglierini, P.
    Lefur, E.
    Pradier, O.
    CANCER RADIOTHERAPIE, 2012, 16 (07): : 601 - 603
  • [39] ROLE OF ADAPTIVE RADIOTHERAPY IN LOCALLY ADVANCED HEAD AND NECK CANCER: A DOSIMETRIC ANALYSIS
    Sharma, S. K.
    Dewan, A.
    Dewan, A. K.
    Pahuja, A.
    Pal, M.
    Rawat, S.
    Mitra, S.
    Sharma, M. K.
    Tandon, S.
    Narang, R.
    Mishra, M.
    EUROPEAN JOURNAL OF CANCER, 2015, 51 : E6 - E6
  • [40] Dosimetric study of Adaptive radiotherapy (ART) for locally advanced head and neck cancer
    Das, J.
    Goswami, B.
    Goswami, S.
    Deka, K. J.
    Bora, G.
    Das, L.
    RADIOTHERAPY AND ONCOLOGY, 2021, 161 : S1271 - S1272